1345 GMT - Bayer's proposed nationwide class settlement of U.S. Roundup claims is a decisive step toward containing the long-running litigation and its financial fallout, MWB Research analyst Abed Jarad writes in a note. This step forward "materially increases the likelihood of durable closure versus a standalone litigation path," the analyst adds. Shares in the German pharmaceutical and agriculture conglomerate are down 11% at 44.02 euros. (william.gray@wsj.com)
(END) Dow Jones Newswires
February 18, 2026 08:45 ET (13:45 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.